W1594A lacks H3K4me3 binding but does not significantly change the affinity for CYP33 RRM. to PHD3 and binding of the CYP33 RRM domain name to PHD3 are mutually inhibitory, implying that PHD3 is a molecular switch for the transition between activation and repression of target genes. To explore the possible mechanism of CYP33/PHD3-mediated repression, we have analyzed the CYP33 proline isomerase activity on various H3 and H4 peptides and shown selectivity for two sites in H3. Our results provide a possible mechanism for the MLL PHD3 domain name to act as a switch between activation and repression. TheMLLgene is usually involved in chromosomal rearrangements that result in a variety of acute leukemias, including de novo acute leukemia, therapy-induced acute myeloid leukemia, and most infant leukemia (16). Human MLL1is a large protein consisting of 3969 amino acids containing multiple functional domains, including three AT-hook motifs, a CXXC zinc finger, two speckled nuclear localization signals, four PHD zinc fingers, a bromo domain name, two FY-rich regions, a transcriptional activation domain name, and a Su(var.)3-9, Enhancer of Zeste, Trithorax (SET) domain name (79). MLL regulates expression of a large number of genes during embryonic development and hematopoiesis. Like itsDrosophilahomologue Trithorax (trx), MLL associates with chromatin and writes an epigenetic mark on lysine 4 of histone H3 (H3K4) through the methyltransferase activity of the C-terminal SET domain name (9,10). Trimethylation on H3K4 (H3K4me3) is usually a global mark for transcriptional activation, and high levels of H3K4me3 are observed in transcriptionally active regions of MLL target genes (11,12). MLL belongs to the Trithorax group (Trx-G) of proteins that are responsible for epigenetic memory of the transcriptionally open or active chromatin says in development and differentiation (13). Trx-G proteins antagonize silencing by the Polycomb group of proteins (Pc-G) (14). The balance of Trx-G andPc-G functions to maintain a transcriptionally active or repressive state has to be elaborately regulated depending on the particular developmental stage. Direct conversation between MLL andPc-G proteins, HPC2 and Bmi-1, has been reported, suggesting that physical cross-talk between Trx-G andPc-G proteins is likely to be involved in the transition between activation and repression of target genes (15). It has been shown that nuclear Cyclophilin33 (CYP33) mediates this transition by binding to the third PHD finger (PHD3) of MLL (16). CYP33 contains an N-terminal RRM (RNA-recognition motif) domain name and a C-terminal cyclophilin domain name that has peptidyl-proline isomerase (PPIase) activity (17,18). Nifuratel The role of the PPIase activity in the biological function of CYP33 and the mechanism of how CYP33 modulates MLL function are still obscure. PHD fingers are frequently found in chromatin-associated proteins, Mouse monoclonal to IL-2 realizing either methylated or unmethylated lysines of histone proteins (1925). MLL has four PHD fingers whose function is mostly unknown. All the PHD fingers as well as the SET domain name are absent in MLL chromosomal translocations found in leukemia. Recently, it was shown that reinsertion of PHD3 into MLLAF9 and MLLENL fusion proteins abrogates immortalization of hematopoietic progenitor cells with a reduction in the level of expression of crucial fusion protein targets such asHOXA9orHOXC8, indicating that PHD3 has a crucial role Nifuratel in MLL function (26,27). Herein, we show that CYP33 mediates downregulation of Nifuratel the expression of MLL target genesHOXC8,HOXA9,CDKN1B, andC-MYC, in a PPIase-dependent manner. This downregulation correlates with reduction of trimethylated lysine 4 of histone H3 (H3K4me3) and histone H3 acetylation. We have structurally characterized both the PHD3 and CYP33 RRM domains using NMR spectroscopy. Chemical shift perturbation analysis, Ala mutagenesis, and isothermal titration calorimetry have been used to show that H3K4me3 and CYP33 RRM bind at unique sites on PHD3. A similar analysis with the RRM domain name shows that PHD3 binds on a site that overlaps with the canonical RNA binding site around the CYP33 RRM domain name. Our binding data show that binding of H3K4me3 to PHD3 and binding of the CYP33 RRM domain name to PHD3 are mutually inhibitory, implying that PHD3 is a molecular switch for the transition between activation and repression of target genes. To explore the possible mechanism of CYP33/PHD3-mediated repression, we have analyzed CYP33 proline isomerase activity on various H3 and H4 peptides and shown selectivity for two sites in H3. Our results provide a possible mechanism for the MLL PHD3 domain name to act as a switch between activation and repression. == Experimental Procedures == == Protein and Peptide Preparation == DNA encoding MLL PHD3 [A1564H1628 of human MLL (gi 56550039)] was cloned into the pGEX-4T-1 vector between theBamHI site and theNotI site. Recombinant PHD3 was expressed inEscherichia coliBL21 cells grown in LB or EMBL medium. Samples for NMR experiments were prepared by addition of appropriate isotopes.